Infection  >>  cyclosporin A microemulsion  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporin A microemulsion / Generic mfg.
EVEREST, NCT01276457: Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Completed
3
223
Europe
Everolimus 0.25 and 0.75 mg tablets, Cyclosporine very low dose (150-300 ng/mL) microemulsion, Neoral, Cyclosporine low dose (350-500 ng/mL) microemulsion
Novartis Pharmaceuticals
Transplantation Infection
02/09
02/09
NCT00149890 / 2015-003528-29: Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids

Completed
3
77
Europe
Basiliximab, Simulect®, Cyclosporine/cyclosporine microemulsion, Sandimmun®/Sandimmun® Optoral, Steroid
Novartis
Liver Transplantation, Infection
03/09
03/09
NCT00075478: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Completed
3
87
US, Europe
Total-Body Irradiation, TBI, Total Body Irradiation, Whole-Body Irradiation, Fludarabine Phosphate, 2-F-ara-AMP, Beneflur, SH T 586, Mycophenolate Mofetil, Cellcept, MMF, Cyclosporine, 27-400, CsA, Neoral, OL 27-400, Sandimmun, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, Peripheral Blood Progenitor Cell Transplantation, Peripheral Stem Cell Support, Peripheral Stem Cell Transplantation
Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Indolent Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Plasma Cell Myeloma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Waldenstrom Macroglobulinemia
02/14
02/14
NCT00919815: Ciclosporin in the Management of New Type 1 Reactions in Leprosy

Completed
2/3
73
RoW
Ciclosporin, Cyclosporine, Cyclosporine A, Prednisolone, corticosteroids
London School of Hygiene and Tropical Medicine, Homes and Hospitals of St Giles, Alert Hospital, Ethiopia, Armauer Hansen Research Institute, Ethiopia
Leprosy
12/12
07/13

Download Options